Why proven innovations still struggle to spread across the NHS
The NHS is not short of innovation. Across the country, new technologies, models of care and clinical interventions are emerging every day with the potential to improve outcomes for patients and make better use of stretched resources.
The challenge is not generating great ideas. It is ensuring proven innovations are adopted, spread and embedded across the health and care system.
That question sat at the heart of the latest NHS Innovation Accelerator (NIA) Quarterly Event in partnership with the Behavioural Insights Team (BIT), where innovators, NHS leaders and policymakers came together to explore one of healthcare’s biggest challenges: why effective innovations still struggle to reach the people who could benefit from them most.
“The NHS is not short of innovation. Across the country, we see brilliant ideas, technologies and new models of care emerging every day. The real challenge is ensuring effective innovations don’t remain isolated successes but become embedded in routine practice so that more patients and healthcare professionals can benefit. Bringing together innovators, NHS leaders and policymakers in this way helps us identify the barriers to adoption and, importantly, the opportunities to overcome them.”
While the technologies and approaches discussed during the day ranged from AI-powered tools to new models of care, conversations repeatedly returned to the same issue: innovation often struggles to move beyond successful pilots into widespread adoption.
Participants described a health system rich with evidence-based solutions but one where systemic and behavioural barriers can slow progress. Common challenges included complex procurement processes, fragmented funding arrangements, unclear approval pathways, and organisational incentives that can make it difficult for local leaders to invest in new approaches, even when the evidence is strong.
Alongside these structural barriers, discussions highlighted the role of human behaviour in shaping innovation adoption. Clinicians and managers operate in busy environments where decisions are made under significant pressure, making it difficult for new ideas to gain traction unless they fit naturally into existing workflows.
“Innovators often assume that if the evidence is strong enough, adoption will follow. But clinicians and managers make decisions under real pressure, and how evidence is framed, who it comes from and where it appears in their working day all shape whether something new gets picked up. The encouraging part is that these behavioural barriers can be designed out.”
The roundtable discussions explored how both systemic and behavioural barriers might be addressed. Participants highlighted the need for clearer pathways for adoption, greater alignment between evidence generation and procurement processes, and stronger support for NHS organisations seeking to implement proven innovations. There was also discussion about designing implementation strategies that reflect how decisions are actually made in clinical settings, rather than assuming evidence alone will drive change.
There was a strong consensus that healthcare must increasingly focus on outcomes that matter to people, whether that is improving recovery, reducing waiting times, supporting mental wellbeing or giving clinicians more time for patient care. Participants argued that success should be measured not by how many innovations are developed, but by how effectively they improve experiences and outcomes at scale.
The discussions also explored the opportunities and challenges presented by artificial intelligence. While enthusiasm for AI remains high, participants stressed that trust, governance and data quality will be just as important as technological capability if these tools are to improve patient outcomes safely and effectively. Without confidence in the evidence and the systems that support it, even promising technologies may struggle to achieve widespread adoption.
Perhaps the most important takeaway from the day was that innovation is not ultimately about technology. It is about people. It is about understanding how clinicians make decisions, how organisations manage risk, and how patients experience care. The future of healthcare innovation will depend not only on creating effective solutions, but on creating the conditions that allow those solutions to spread.
“The next chapter for healthcare innovation will not be defined by how many new solutions we create, but by how effectively we embed proven solutions into everyday care. The opportunity ahead is to make innovation the norm rather than the exception, ensuring more patients benefit from the advances already available to us today.”
“The next chapter for healthcare innovation will not be defined by how many new solutions we create, but by how effectively we embed proven solutions into everyday care. The opportunity ahead is to make innovation the norm rather than the exception, ensuring more patients benefit from the advances already available to us today.”
The message from the event was clear: the NHS already has many of the innovations it needs. The next challenge is overcoming the behavioural, cultural and systemic barriers that prevent proven solutions from becoming routine practice. If those obstacles can be addressed, the opportunity is not simply to innovate more, but to deliver better care for more people, more quickly.
